<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AValuation_risk</id>
	<title>Definition:Valuation risk - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3AValuation_risk"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Valuation_risk&amp;action=history"/>
	<updated>2026-06-14T05:14:15Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Valuation_risk&amp;diff=16622&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Valuation_risk&amp;diff=16622&amp;oldid=prev"/>
		<updated>2026-03-15T06:35:46Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;⚠️ &amp;#039;&amp;#039;&amp;#039;Valuation risk&amp;#039;&amp;#039;&amp;#039; refers to the possibility that an insurer&amp;#039;s assets or liabilities are misstated on its [[Definition:Balance sheet | balance sheet]], leading to an inaccurate picture of the company&amp;#039;s financial health and [[Definition:Solvency | solvency]] position. In the insurance context, this risk is particularly acute because insurers hold vast portfolios of financial instruments — bonds, equities, structured products, real estate — alongside [[Definition:Technical provisions | technical provisions]] for future claims that require complex actuarial estimation. Unlike a manufacturing firm whose inventory can be counted and priced against observable markets, an insurer&amp;#039;s largest liabilities are inherently forward-looking and uncertain, making valuation both critically important and unusually difficult.&lt;br /&gt;
&lt;br /&gt;
📊 The mechanics of valuation risk play out differently on each side of the balance sheet. On the asset side, insurers face mark-to-market volatility for traded instruments and model-dependent uncertainty for illiquid holdings such as [[Definition:Private equity | private equity]] investments, infrastructure debt, or [[Definition:Insurance-linked securities (ILS) | insurance-linked securities]]. On the liability side, [[Definition:Reserves | reserve]] estimates depend on actuarial assumptions about [[Definition:Loss development | loss development]], discount rates, policyholder behavior (such as [[Definition:Lapse rate | lapse rates]] in life insurance), and mortality or morbidity projections — any of which may prove inaccurate. Regulatory regimes address valuation risk through distinct frameworks: [[Definition:Solvency II | Solvency II]] in Europe mandates a market-consistent valuation of both assets and liabilities, while U.S. [[Definition:Statutory accounting | statutory accounting]] under the [[Definition:National Association of Insurance Commissioners (NAIC) | NAIC]] framework uses more conservative, rules-based approaches with prescribed valuation methods for certain asset classes. The introduction of [[Definition:IFRS 17 | IFRS 17]] has further reshaped liability valuation globally by requiring a current fulfillment value approach, including an explicit [[Definition:Risk adjustment | risk adjustment]] and a [[Definition:Contractual service margin (CSM) | contractual service margin]].&lt;br /&gt;
&lt;br /&gt;
🔍 Underestimating valuation risk has contributed to some of the insurance industry&amp;#039;s most consequential failures and crises. When asset values prove overstated — as occurred widely during the 2008 financial crisis with mortgage-backed securities held by insurers — or when liability reserves prove deficient, the resulting solvency shortfall can trigger regulatory intervention, [[Definition:Rating downgrade | rating downgrades]], or forced [[Definition:Run-off | run-off]]. Boards and senior management rely on robust [[Definition:Enterprise risk management (ERM) | enterprise risk management]] frameworks to monitor valuation risk through stress testing, sensitivity analysis, and independent actuarial review. [[Definition:External audit | External auditors]] and regulators serve as additional lines of defense, but the judgment-intensive nature of insurance valuation means that no amount of oversight eliminates the risk entirely. For investors, analysts, and [[Definition:Rating agency | rating agencies]], understanding an insurer&amp;#039;s valuation methodology and the degree of management discretion embedded in reported figures is essential to assessing the true strength of its capital position.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Technical provisions]]&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:IFRS 17]]&lt;br /&gt;
* [[Definition:Reserve risk]]&lt;br /&gt;
* [[Definition:Enterprise risk management (ERM)]]&lt;br /&gt;
* [[Definition:Statutory accounting]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>